According to the trial protocol for compassionate
Post# of 148281
There were 9 patients from the phase 2b/3 and 21 from compassionate.
Quote:
This is the part I'm not sure about: Those 22 showed the big increases in the ratio(?) of modified progression-free survival to 12 month progression-free survival and in the ratio of modified overall survival to 12 month modified survival.
I think the lower numbers are for PFS/OS and the higher numbers are for mOS and mPFS.